title: Early experience with FK 506 induction immunosuppression--suggestion for using oral FK 506.
authors.affiliation: Pacific Transplant Institute, California Pacific Medical Center, San Francisco 94115.
authors.forename: P
authors.initials: P
authors.lastname: Nakazato
authors.forename: K
authors.initials: K
authors.lastname: Cox
authors.forename: W
authors.initials: W
authors.lastname: Concepcion
authors.forename: R
authors.initials: R
authors.lastname: Gish
authors.forename: W
authors.initials: W
authors.lastname: Berquist
authors.forename: J
authors.initials: J
authors.lastname: Imperial
authors.forename: C
authors.initials: C
authors.lastname: Esquivel
mesh_terms: D000284:Administration, Oral; D000328:Adult; D002648:Child; D005500:Follow-Up Studies; D006801:Humans; D007165:Immunosuppression Therapy / Q000379:methods; D016031:Liver Transplantation / Q000276:immunology* / Q000502:physiology; D016559:Tacrolimus / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*
chemical_list: D016559:Tacrolimus